Artivion | CRY - 销售成本

股票价格

35.29

每天变化

-1.10 -3.02%

每月一次

-8.46%

每年

45.53%

Q1 预测

35.04

金融业

USD

USD 884.8M

现金及等价物

USD 64.91M

USD 42.85M

USD 358.08M

USD 101.56M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 448.23M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 217.81M

USD 1.46B

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 92.43M

贸易债权人

USD 16.04M

应收帐款人

USD 103.68M

	销售成本	更改		日
Abbott	USD 4.92B		535M	2025-12
Accuray	USD 116.17M		14.63M	2024-12
AngioDynamics	USD 37.29M		786K	2025-09
Artivion	USD 42.85M		3.86M	2025-12
AtriCure	USD 35.16M		2.23M	2025-12
Baxter International	USD 2.4B		512M	2025-12
Becton, Dickinson and Co.	USD 2.84B		2.35B	2025-12
Boston Scientific	USD 1.84B		82M	2025-12
Edwards Lifesciences	USD 343M		2.2M	2025-12
Inogen	USD 39.59M		1.27M	2024-09
Integra LifeSciences	USD 193.44M		1.62M	2025-12
J&J	USD 7.97B		689M	2025-12
Mesa Laboratories	USD 21.92M		1.78M	2024-09
Orthofix International	USD 66.63M		6.4M	2025-12
Pfizer	USD 6.29B		2.12B	2025-12
ResMed	USD 555.85M		29.13M	2025-12
Stryker	USD 2.69B		373M	2025-12
Surmodics	USD 33.03M		24.58M	2024-09
Tandem Diabetes Care	USD 122.92M		7.96M	2025-12
Teleflex	USD 261.54M		199.84M	2025-12
Terumo	JPY 143.44B		15.47B	2025-12
Trinity Biotech	USD 7.84M		3.14M	2025-09